Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse

Sigrun Vehling; Uwe Koch-Gromus; Natalie Ladehoff; Gerhard Schön; Karl Wegscheider; Ulrike Heckl; Joachim Weis; Anja Mehnert

doi:10.1055/s-0032-1309032

Prävalenz affektiver und Angststörungen bei Krebs

Standard

Prävalenz affektiver und Angststörungen bei Krebs : Systematischer Literaturreview und Metaanalyse. / Vehling, Sigrun ; Koch-Gromus, Uwe; Ladehoff, Natalie; Schön, Gerhard ; Wegscheider, Karl; Heckl, Ulrike; Weis, Joachim; Mehnert, Anja.

in: PSYCHOTHER PSYCH MED, Jahrgang 62, Nr. 7, 01.07.2012, S. 249-58.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Vehling, S , Koch-Gromus, U, Ladehoff, N, Schön, G , Wegscheider, K, Heckl, U, Weis, J & Mehnert, A 2012, 'Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse', PSYCHOTHER PSYCH MED, Jg. 62, Nr. 7, S. 249-58. https://doi.org/10.1055/s-0032-1309032

APA

Vehling, S., Koch-Gromus, U., Ladehoff, N., Schön, G., Wegscheider, K., Heckl, U., Weis, J., & Mehnert, A. (2012). Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse. PSYCHOTHER PSYCH MED, 62(7), 249-58. https://doi.org/10.1055/s-0032-1309032

Vancouver

Vehling S , Koch-Gromus U, Ladehoff N, Schön G , Wegscheider K, Heckl U et al. Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse. PSYCHOTHER PSYCH MED. 2012 Jul 1;62(7):249-58. https://doi.org/10.1055/s-0032-1309032

Bibtex

@article{2f0c5e939219452f86afe9b74e032ec7,

title = "Pr{\"a}valenz affektiver und Angstst{\"o}rungen bei Krebs: Systematischer Literaturreview und Metaanalyse",

abstract = "We aimed to systematically summarize the empirical evidence on the 4-week-, 12-month-, and lifetime prevalence of affective and anxiety disorders in cancer patients. We evaluated 89 English or German language original papers and systematic reviews that assessed the prevalence of affective and anxiety disorders using structured clinical interviews published between 1995 and 2010. Adjusted prevalence rates were calculated using a random-intercept model. The pooled adjusted 4-week prevalence of affective disorders was 11.1% (95% CI 8.1-15.1), and 10.8% (95% CI 6.8-16.7) based on German studies. The pooled adjusted 4-week prevalence of anxiety disorders was 10.2% (95% CI 6.9-14.8), and 13.5% (95% CI 7.1-24.3) based on German studies. The findings show the need for further research on representative studies that take into account the range of psychosocial stressors and supportive care needs in addition to the prevalence of mental disorders.",

keywords = "Anxiety Disorders, Data Interpretation, Statistical, Humans, Mood Disorders, Neoplasms",

author = "Sigrun Vehling and Uwe Koch-Gromus and Natalie Ladehoff and Gerhard Sch{\"o}n and Karl Wegscheider and Ulrike Heckl and Joachim Weis and Anja Mehnert",

note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",

year = "2012",

month = jul,

day = "1",

doi = "10.1055/s-0032-1309032",

language = "Deutsch",

volume = "62",

pages = "249--58",

journal = "PSYCHOTHER PSYCH MED",

issn = "0937-2032",

publisher = "Georg Thieme Verlag KG",

number = "7",

}

RIS

TY - JOUR

T1 - Prävalenz affektiver und Angststörungen bei Krebs

T2 - Systematischer Literaturreview und Metaanalyse

AU - Vehling, Sigrun

AU - Koch-Gromus, Uwe

AU - Ladehoff, Natalie

AU - Schön, Gerhard

AU - Wegscheider, Karl

AU - Heckl, Ulrike

AU - Weis, Joachim

AU - Mehnert, Anja

N1 - © Georg Thieme Verlag KG Stuttgart · New York.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - We aimed to systematically summarize the empirical evidence on the 4-week-, 12-month-, and lifetime prevalence of affective and anxiety disorders in cancer patients. We evaluated 89 English or German language original papers and systematic reviews that assessed the prevalence of affective and anxiety disorders using structured clinical interviews published between 1995 and 2010. Adjusted prevalence rates were calculated using a random-intercept model. The pooled adjusted 4-week prevalence of affective disorders was 11.1% (95% CI 8.1-15.1), and 10.8% (95% CI 6.8-16.7) based on German studies. The pooled adjusted 4-week prevalence of anxiety disorders was 10.2% (95% CI 6.9-14.8), and 13.5% (95% CI 7.1-24.3) based on German studies. The findings show the need for further research on representative studies that take into account the range of psychosocial stressors and supportive care needs in addition to the prevalence of mental disorders.

AB - We aimed to systematically summarize the empirical evidence on the 4-week-, 12-month-, and lifetime prevalence of affective and anxiety disorders in cancer patients. We evaluated 89 English or German language original papers and systematic reviews that assessed the prevalence of affective and anxiety disorders using structured clinical interviews published between 1995 and 2010. Adjusted prevalence rates were calculated using a random-intercept model. The pooled adjusted 4-week prevalence of affective disorders was 11.1% (95% CI 8.1-15.1), and 10.8% (95% CI 6.8-16.7) based on German studies. The pooled adjusted 4-week prevalence of anxiety disorders was 10.2% (95% CI 6.9-14.8), and 13.5% (95% CI 7.1-24.3) based on German studies. The findings show the need for further research on representative studies that take into account the range of psychosocial stressors and supportive care needs in addition to the prevalence of mental disorders.

KW - Anxiety Disorders

KW - Data Interpretation, Statistical

KW - Humans

KW - Mood Disorders

KW - Neoplasms

U2 - 10.1055/s-0032-1309032

DO - 10.1055/s-0032-1309032

M3 - SCORING: Zeitschriftenaufsatz

C2 - 22585582

VL - 62

SP - 249

EP - 258

JO - PSYCHOTHER PSYCH MED

JF - PSYCHOTHER PSYCH MED

SN - 0937-2032

IS - 7

ER -